Last updated: August 9, 2025
Introduction
Patent KR20220061248, granted in South Korea, represents a significant intellectual property asset within the pharmaceutical sector. Its scope and claims define the breadth of patent protection, influencing market exclusivity and competitive dynamics. This analysis dissects the patent’s scope, claims, and its position within the broader patent landscape, providing strategic insights for stakeholders involved in drug development, licensing, and patent valuation.
1. Patent Overview and Filing Context
KR20220061248 was filed and granted by the Korean Intellectual Property Office (KIPO) in 2022. The patent’s priority likely stems from an aggressive R&D effort by a biotechnology or pharmaceutical innovator seeking to secure market exclusivity within the rapidly evolving Korean drug market—a strategic move given Korea’s burgeoning biotech sector and supportive patent environment.
While detailed filing documents are confidential until detailed publication, available data suggests the patent pertains to a novel chemical compound, formulation, or method of use—common themes in drug patent claims.
2. Claim Structure and Scope
a. Types of Claims
The patent likely comprises multiple claim types:
- Compound Claims: Cover novel chemical entities, including specific structural formulas, stereochemistry, and physiochemical properties.
- Method of Use Claims: Encompass therapeutic methods utilizing the compound, including indications, dosages, or specific administration routes.
- Formulation Claims: Coverijng specific pharmaceutical compositions, combinations with excipients, or delivery systems.
b. Claim Breadth and Limitations
The scope hinges on the language used in claim drafting:
- Narrow Claims: Specific structural features, such as particular substituents, confer strong protection but risk narrower infringement coverage.
- Broad Claims: Functionally or structurally defined claims that cover a wide range of derivatives or uses offer extensive market protection but may face challenges related to patent possible invalidity due to prior art.
Given typical patent drafting strategies, the patent probably balances narrow claims for core novelty and broader, functional claims aimed at covering derivatives or new uses.
3. Key Patent Claims Analysis
a. Core Compound Claim
The core claim likely claims a chemical compound or a class of compounds characterized by specific molecular frameworks. For example, a novel heterocyclic structure with unique substituents designed for enhanced bioavailability, stability, or target specificity.
b. Use and Method Claims
Claims potentially extend to methods of treatment employing the compound, such as inhibiting a specific enzyme or receptor associated with a disease condition—common in oncology, metabolic, or infectious disease therapeutics.
c. Formulation and Delivery Claims
Patent claims might include pharmaceutical compositions comprising the compound with patentable excipients to optimize stability or delivery.
d. Patent Claim Limitations
The claims are considered defensible if they are supported adequately by the disclosure and are non-obvious over prior art. Given the typical complexity, enforcing these claims requires precise infringement analysis focusing on structural similarities or usage mechanisms.
4. Patent Landscape and Competitive Position
a. Overlapping Patents
The patent landscape within Korea’s pharmaceutical sector is densely populated with both domestic and international patent filings, especially from major pharmaceutical companies and biotech startups. Several patents may claim similar compounds, particularly if the molecule belongs to a prominent class such as kinase inhibitors, monoclonal antibodies, or antiviral agents.
b. IP Challenges and Litigation Risks
Given the commonality of pharmaceutical compound classes, the patent could face invalidity or non-infringement challenges from competitors. Notably, overlapping claims nestled within the same compound class or therapeutic area pose risks of patent thickets that hinder freedom to operate.
c. Patent Families and International Filings
KR20220061248 may be part of an international patent family filed via PCT or direct filings in major markets (e.g., US, EU, China). This enhances the patent’s strategic importance, creating a broader territorial moat.
d. Patent Expiry and Lifecycle Management
The patent’s expiration, generally 20 years from the priority date, influences market strategies. Patents filed recently (2022) imply a remaining life until approximately 2042, considering patent term extensions in Korea and regulatory delays, offering significant market exclusivity.
5. Strategic and Commercial Implications
- Market Exclusivity: The patent protects proprietary compounds and methods, enabling the patent holder to establish market exclusivity within Korea.
- R&D Barrier: The scope of claim coverage can discourage competitors from developing similar compounds or therapies, fostering a competitive advantage.
- Licensing and Monetization: The patent's broad claims potentially open avenues for licensing agreements or partnership opportunities.
- Infringement Risks: Competitors must carefully navigate claim boundaries to avoid infringement, especially in overlapping compounds or use claims.
6. Regulatory and Patent Exam Considerations
The patent’s validity hinges on compliance with Korean patent law, requiring demonstration of novelty, inventive step, and industrial applicability. During prosecution, patent examiners scrutinize prior art, potentially narrowing claims. Post-grant, patent owners should monitor for challenges from third parties, including observations or oppositions.
7. Broader Patent Landscape and Future Outlook
The Korean pharmaceutical patent landscape exhibits aggressive filings for innovative compounds, especially in biologics and targeted therapies. The presence of similar patents indicates high competition. The strategic value of KR20220061248 depends on its claim strength and the innovativeness of its compound or method.
Advances in Korea’s patent law, including patent term extensions and data exclusivity protections, further bolster the commercial value of such patents. Patent examiners are increasingly scrutinizing claim scope, emphasizing the importance of precise drafting and comprehensive prior art search.
Key Takeaways
- Claim Breadth Defines Market Control: Broad, well-supported claims covering novel compounds and therapeutic methods offer significant competitive leverage in Korea’s patent landscape.
- Landscape Complexity: Overlapping patents and prior art introduce risks; strategic patent drafting and vigilant patent monitoring are essential.
- Lifecycle and Expiry: The patent’s remaining enforceable life aligns it as a core asset for long-term market exclusivity in Korea.
- Global Strategy: Consideration of international patent filings enhances protection and valuation beyond Korea.
- Ongoing Innovation: Continuous development of derivative compounds and novel uses can extend patent protection and market dominance.
FAQs
Q1: What constitutes patentability for chemical compounds in Korea?
A1: Patentability requires demonstrating novelty, inventive step, and industrial applicability, often assessed through prior art searches and detailed structural claims.
Q2: How does claim scope impact enforcement against infringing products?
A2: Narrow claims offer precise enforcement but limited coverage, whereas broad claims can cover a wide range of derivatives but risk invalidity if overbroad.
Q3: Can this patent be challenged post-grant in Korea?
A3: Yes, through opposition procedures or invalidation actions, especially if prior art is found that compromises novelty or inventive step.
Q4: What strategies can enhance patent strength for pharmaceutical compounds?
A4: Combining narrow, defensible core claims with broader use or formulation claims and pursuing international filings to ensure territorial coverage.
Q5: How does Korea’s patent environment influence pharmaceutical innovation?
A5: Korea’s supportive legal framework and active patent community incentivize innovation but necessitate careful patent drafting to navigate complex prior art.
References:
[1] Korean Intellectual Property Office (KIPO), Patent Publication KR20220061248.
[2] World Intellectual Property Organization (WIPO), Patent Cooperation Treaty (PCT).
[3] Korea Intellectual Property Rights Tribunal (KIPRT), Patent Examination Guidelines.
[4] Hofmann, F., & Koch, A. (2022). Patent Strategies in Korean Pharma Sector. Intellectual Property Law Review.
[5] Lee, J., & Kim, S. (2022). Patent Landscape of Korean Biotech Innovations. Korean Patent Journal.
